$TMGI
Marquie Group, Inc.

2023 Q2 Form 10-Q Financial Statement

#000168316823002566 Filed on April 21, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $103.9K $69.47K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $230.00 $230.00
YoY Change
% of Gross Profit
Operating Expenses $103.9K $69.47K $72.22K
YoY Change -3.82%
Operating Profit -$69.47K -$72.22K
YoY Change -3.82%
Interest Expense $435.1K $102.5K $123.4K
YoY Change -16.93%
% of Operating Profit
Other Income/Expense, Net -$603.8K -$532.9K
YoY Change 13.3%
Pretax Income $331.2K -$673.3K -$605.1K
YoY Change 11.26%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $331.2K -$673.3K -$605.1K
YoY Change 11.26%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 -$0.05
Diluted Earnings Per Share $0.00 $0.00 -$0.05
COMMON SHARES
Basic Shares Outstanding 756.6M shares 756.6M shares 13.12M shares
Diluted Shares Outstanding 756.6M shares 13.12M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $50.00
YoY Change
Cash & Equivalents $0.00 $45.00 $21.90K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $929.00 $1.159K $2.556K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $45.00
YoY Change -100.0%
LONG-TERM ASSETS
Property, Plant & Equipment $930.00 $1.160K
YoY Change
Goodwill
YoY Change
Intangibles $10.37K $10.37K
YoY Change 0.0%
Long-Term Investments $6.200M $6.200M
YoY Change
Other Assets $6.240M $6.235M
YoY Change 49688.87%
Total Long-Term Assets $6.240M $6.235M
YoY Change 49688.87%
TOTAL ASSETS
Total Short-Term Assets $0.00 $45.00
Total Long-Term Assets $6.240M $6.235M
Total Assets $6.240M $6.235M
YoY Change 48324.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $50.66K $69.41K
YoY Change 43.1%
Accrued Expenses $1.724M $1.575M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $3.556M $3.512M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.367M $6.693M
YoY Change 12.33%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $6.367M $6.693M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $6.367M $6.693M
YoY Change 12.33%
SHAREHOLDERS EQUITY
Retained Earnings -$14.70M -$15.03M
YoY Change -7.43%
Common Stock $75.66K $75.66K
YoY Change 4567.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$127.0K -$458.2K -$3.853M
YoY Change
Total Liabilities & Shareholders Equity $6.240M $6.235M
YoY Change 48324.84%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $331.2K -$673.3K -$605.1K
YoY Change 11.26%
Depreciation, Depletion And Amortization $230.00 $230.00
YoY Change
Cash From Operating Activities -$74.11K -$11.54K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$5.000K -$14.00K
YoY Change
Cash From Investing Activities -$5.000K -$14.00K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 79.06K 24.80K
YoY Change
NET CHANGE
Cash From Operating Activities -74.11K -11.54K
Cash From Investing Activities -5.000K -14.00K
Cash From Financing Activities 79.06K 24.80K
Net Change In Cash -50.00 -740.0
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$74.11K -$11.54K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001434601
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-02-28
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54163
dei Entity Registrant Name
EntityRegistrantName
The Marquie Group, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-2091212
dei Entity Address Address Line1
EntityAddressAddressLine1
7901 4th ST N
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 4000
dei Entity Address City Or Town
EntityAddressCityOrTown
St. Petersburg
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33702
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33702
dei City Area Code
CityAreaCode
800
dei Local Phone Number
LocalPhoneNumber
351-3021
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
756612000 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
353 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
45 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
353 usd
CY2023Q1 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
6200000 usd
CY2022Q2 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
0 usd
CY2023Q1 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
23247 usd
CY2022Q2 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
0 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20489 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19481 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
1159 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
2167 usd
CY2023Q1 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
10365 usd
CY2022Q2 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
10365 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6234771 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12532 usd
CY2023Q1 us-gaap Assets
Assets
6234816 usd
CY2022Q2 us-gaap Assets
Assets
12885 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
69414 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
35405 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
483388 usd
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
334180 usd
CY2023Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1091517 usd
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
926217 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
31709 usd
CY2022Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
6889 usd
CY2023Q1 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
1439122 usd
CY2022Q2 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
1419108 usd
CY2023Q1 TMGI Notes Payable To Related Parties Current
NotesPayableToRelatedPartiesCurrent
2072851 usd
CY2022Q2 TMGI Notes Payable To Related Parties Current
NotesPayableToRelatedPartiesCurrent
135551 usd
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1536695 usd
CY2022Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2817101 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6692987 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5667562 usd
CY2023Q1 us-gaap Liabilities
Liabilities
6692987 usd
CY2022Q2 us-gaap Liabilities
Liabilities
5667562 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
200 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
200 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
200 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
200 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
756612000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
756612000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16189732 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16189732 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
75663 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
1621 usd
CY2023Q1 TMGI Common Stock Payable
CommonStockPayable
8460 usd
CY2022Q2 TMGI Common Stock Payable
CommonStockPayable
8460 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14486896 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10213431 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15029190 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15878189 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-458171 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-5654677 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6234816 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12885 usd
CY2023Q1 us-gaap Revenues
Revenues
0 usd
CY2022Q1 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2023Q1 us-gaap Salaries And Wages
SalariesAndWages
60000 usd
CY2022Q1 us-gaap Salaries And Wages
SalariesAndWages
30000 usd
us-gaap Salaries And Wages
SalariesAndWages
180000 usd
us-gaap Salaries And Wages
SalariesAndWages
90000 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
8096 usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
27763 usd
us-gaap Professional Fees
ProfessionalFees
59209 usd
us-gaap Professional Fees
ProfessionalFees
68648 usd
CY2023Q1 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
1369 usd
CY2022Q1 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
14459 usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
13370 usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
23525 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
69465 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
72222 usd
us-gaap Operating Expenses
OperatingExpenses
252579 usd
us-gaap Operating Expenses
OperatingExpenses
182173 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-69465 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-72222 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-252579 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-182173 usd
CY2023Q1 TMGI Gain On Settlement Of Debt
GainOnSettlementOfDebt
0 usd
CY2022Q1 TMGI Gain On Settlement Of Debt
GainOnSettlementOfDebt
260032 usd
TMGI Gain On Settlement Of Debt
GainOnSettlementOfDebt
0 usd
TMGI Gain On Settlement Of Debt
GainOnSettlementOfDebt
260032 usd
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-501275 usd
CY2022Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-388102 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1349841 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1168456 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
17120 usd
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
67186 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
44614 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
259354 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
102520 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
123412 usd
us-gaap Interest Expense
InterestExpense
248263 usd
us-gaap Interest Expense
InterestExpense
531936 usd
CY2023Q1 TMGI Income Loss On Conversion Of Notes Payable And Accrued Interest
IncomeLossOnConversionOfNotesPayableAndAccruedInterest
0 usd
CY2022Q1 TMGI Income Loss On Conversion Of Notes Payable And Accrued Interest
IncomeLossOnConversionOfNotesPayableAndAccruedInterest
-281425 usd
TMGI Income Loss On Conversion Of Notes Payable And Accrued Interest
IncomeLossOnConversionOfNotesPayableAndAccruedInterest
0 usd
TMGI Income Loss On Conversion Of Notes Payable And Accrued Interest
IncomeLossOnConversionOfNotesPayableAndAccruedInterest
-2810824 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-603795 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-532907 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1101578 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1914272 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-673260 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-605129 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
848999 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2096445 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-673260 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-605129 usd
us-gaap Net Income Loss
NetIncomeLoss
848999 usd
us-gaap Net Income Loss
NetIncomeLoss
-2096445 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
756612000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
756612000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13123087 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13123087 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
451229140 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
451229140 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9318259 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9318259 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-5654677 usd
CY2022Q3 us-gaap Stock Option Down Round Feature Increase Decrease In Equity Amount1
StockOptionDownRoundFeatureIncreaseDecreaseInEquityAmount1
0 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-111440 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-5766117 usd
CY2022Q4 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
147507 usd
CY2022Q4 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
4200000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
1633699 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
215089 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-673260 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-458171 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-4766118 usd
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1503100 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-3002348 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-6265366 usd
CY2021Q4 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1121796 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
1511032 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-3632539 usd
CY2022Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
384358 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-605129 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-3853310 usd
us-gaap Net Income Loss
NetIncomeLoss
848999 usd
us-gaap Net Income Loss
NetIncomeLoss
-2096445 usd
us-gaap Depreciation
Depreciation
1008 usd
us-gaap Depreciation
Depreciation
1753 usd
TMGI Gain Loss On Settlement Of Debt
GainLossOnSettlementOfDebt
-0 usd
TMGI Gain Loss On Settlement Of Debt
GainLossOnSettlementOfDebt
260032 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1349841 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1168456 usd
TMGI Amortization Of Debt Discounts
AmortizationOfDebtDiscounts
44614 usd
TMGI Amortization Of Debt Discounts
AmortizationOfDebtDiscounts
280546 usd
TMGI Income Loss On Conversion Of Note Payable And Accrued Interest
IncomeLossOnConversionOfNotePayableAndAccruedInterest
-0 usd
TMGI Income Loss On Conversion Of Note Payable And Accrued Interest
IncomeLossOnConversionOfNotePayableAndAccruedInterest
-2810824 usd
TMGI Default Interest Added To Notes Principal Balance
DefaultInterestAddedToNotesPrincipalBalance
0 usd
TMGI Default Interest Added To Notes Principal Balance
DefaultInterestAddedToNotesPrincipalBalance
103190 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
34009 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
9956 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
196715 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
112778 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
165300 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
76950 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-59196 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-128936 usd
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
23247 usd
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
-0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23247 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
0 usd
us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
-1140 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
94835 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
348250 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
-0 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
200500 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
12700 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
27272 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
31500 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
82135 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
150838 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-308 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
21902 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
353 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21902 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
TMGI Issuance Of Stock And Promissory Note For Investment In Acquisition
IssuanceOfStockAndPromissoryNoteForInvestmentInAcquisition
6200000 usd
TMGI Issuance Of Stock And Promissory Note For Investment In Acquisition
IssuanceOfStockAndPromissoryNoteForInvestmentInAcquisition
0 usd
TMGI Initial Derivative Liability Charged To Debt Discounts
InitialDerivativeLiabilityChargedToDebtDiscounts
0 usd
TMGI Initial Derivative Liability Charged To Debt Discounts
InitialDerivativeLiabilityChargedToDebtDiscounts
283596 usd
TMGI Conversion Of Debt And Accrued Interest Into Common Stock
ConversionOfDebtAndAccruedInterestIntoCommonStock
147507 usd
TMGI Conversion Of Debt And Accrued Interest Into Common Stock
ConversionOfDebtAndAccruedInterestIntoCommonStock
198429 usd
CY2022Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
1425997 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-31709 usd
CY2022Q2 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-6889 usd
CY2023Q1 us-gaap Inventory Gross
InventoryGross
21648 usd
CY2022Q2 us-gaap Inventory Gross
InventoryGross
21648 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20489 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19481 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
1159 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
2167 usd
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
0 usd
us-gaap Depreciation
Depreciation
1008 usd
us-gaap Depreciation
Depreciation
1753 usd
CY2023Q1 us-gaap Notes And Loans Payable
NotesAndLoansPayable
1439122 usd
CY2022Q2 us-gaap Notes And Loans Payable
NotesAndLoansPayable
1419108 usd
CY2023Q1 TMGI Notes Payable Related Parties
NotesPayableRelatedParties
2072851 usd
CY2023Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1091517 usd
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
926217 usd
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
926217 usd
CY2021Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
832967 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
180000 usd
CY2022 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
120000 usd
TMGI Payments To Consultants
PaymentsToConsultants
-14700 usd
CY2022 TMGI Payments To Consultants
PaymentsToConsultants
-26750 usd
CY2023Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1091517 usd
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
926217 usd
CY2023Q1 us-gaap Notes And Loans Payable
NotesAndLoansPayable
1439122 usd
CY2022Q2 us-gaap Notes And Loans Payable
NotesAndLoansPayable
1419108 usd
CY2023Q1 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
1439122 usd
CY2022Q2 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
1419108 usd
CY2023Q1 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
0 usd
CY2022Q2 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
0 usd
CY2023Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
1470831 usd
CY2022Q2 TMGI Notes Payable Related Parties
NotesPayableRelatedParties
135551 usd
CY2023Q1 TMGI Notes Payable To Related Parties Current
NotesPayableToRelatedPartiesCurrent
2072851 usd
CY2022Q2 TMGI Notes Payable To Related Parties Current
NotesPayableToRelatedPartiesCurrent
135551 usd
CY2023Q1 TMGI Notes Payable To Related Parties Noncurrent
NotesPayableToRelatedPartiesNoncurrent
0 usd
CY2022Q2 TMGI Notes Payable To Related Parties Noncurrent
NotesPayableToRelatedPartiesNoncurrent
0 usd
CY2023Q1 us-gaap Derivative Liability Notional Amount
DerivativeLiabilityNotionalAmount
642417 usd
CY2023Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
1536695 usd
CY2022Q2 us-gaap Derivative Liability Notional Amount
DerivativeLiabilityNotionalAmount
572982 usd
CY2022Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
2817101 usd
CY2023Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
1536695 usd
CY2022Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
2817101 usd
CY2021 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
4304842 shares
CY2021 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
835050 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1445042 usd
CY2022Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 1,000 reverse split
CY2023Q1 TMGI Working Capital
WorkingCapital
6692942 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15029190 usd

Files In Submission

Name View Source Status
0001683168-23-002566-index-headers.html Edgar Link pending
0001683168-23-002566-index.html Edgar Link pending
0001683168-23-002566.txt Edgar Link pending
0001683168-23-002566-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
marquie_ex3101.htm Edgar Link pending
marquie_ex3201.htm Edgar Link pending
marquie_i10q-022823.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
marquie_i10q-022823_htm.xml Edgar Link completed
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmgi-20230228.xsd Edgar Link pending
tmgi-20230228_def.xml Edgar Link unprocessable
tmgi-20230228_cal.xml Edgar Link unprocessable
tmgi-20230228_lab.xml Edgar Link unprocessable
tmgi-20230228_pre.xml Edgar Link unprocessable